UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy

Hepatology (Baltimore, Md.), 2017-03, Vol.65 (3), p.804-812

2017

Volltextzugriff (PDF)

Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin

Hepatology (Baltimore, Md.), 2012-08, Vol.56 (2), p.422-433

2012

Volltextzugriff (PDF)

An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign‐Born Persons Living in the United States

Hepatology (Baltimore, Md.), 2021-08, Vol.74 (2), p.607-626

2021

Volltextzugriff (PDF)

Chronic hepatitis B: A wave of new therapies on the horizon

Antiviral research, 2015-09, Vol.121, p.69-81

2015

Volltextzugriff (PDF)

Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States

Gastroenterology (New York, N.Y. 1943), 2009-11, Vol.137 (5), p.1680-1686

2009

Volltextzugriff (PDF)

Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States

Hepatology (Baltimore, Md.), 2022-04, Vol.75 (4), p.1062-1063

2022

Volltextzugriff (PDF)

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Gastroenterology (New York, N.Y. 1943), 2006-12, Vol.131 (6), p.1743-1751

2006

Volltextzugriff (PDF)

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.800-807

2003

Volltextzugriff (PDF)

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B

Journal of hepatology, 2008-05, Vol.48 (5), p.728-735

2008

Volltextzugriff (PDF)

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-1758

2004

Volltextzugriff (PDF)

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.81-90

2004

Volltextzugriff (PDF)

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2673-2681

2005

Volltextzugriff (PDF)

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.91-101

2004

Volltextzugriff (PDF)

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Journal of hepatology, 2003-12, Vol.39 (6), p.1085-1089

2003

Volltextzugriff (PDF)

Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States

Hepatology (Baltimore, Md.), 2015-11, Vol.62 (5), p.1339-1341

2015

Volltextzugriff (PDF)

Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127

Hepatology (Baltimore, Md.), 2006-11, Vol.44 (5), p.1110-1116

2006

Volltextzugriff (PDF)

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.808-816

2003

Volltextzugriff (PDF)

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop

Antiviral research, 2018-02, Vol.150, p.93-100

2018

Volltextzugriff (PDF)

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

Kidney international, 2004-09, Vol.66 (3), p.1153-1158

2004

Volltextzugriff (PDF)

Adefovir dipivoxil therapy for lamivudine‐resistant hepatitis B in pre– and post–liver transplantation patients

Hepatology (Baltimore, Md.), 2003-12, Vol.38 (6), p.1419-1427, Article ajhep09040

2003

Volltextzugriff (PDF)

Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity

Antimicrobial Agents and Chemotherapy, 2008-01, Vol.52 (1), p.312-320

2008

Volltextzugriff (PDF)

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Journal of Virus Eradication, 2017-01, Vol.3 (1), p.1-6

2017

Volltextzugriff (PDF)

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

Hepatology (Baltimore, Md.), 2003-07, Vol.38 (1), p.96-103

2003

Volltextzugriff (PDF)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Hepatology (Baltimore, Md.), 2023-12, Vol.78 (6), p.1966-1986

2023

Volltextzugriff (PDF)

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease : a randomized, placebo-controlled trial

AIDS (London), 2001-09, Vol.15 (13), p.1695-1700

2001

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(88)

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Humans
(44)
Male
(32)
Adult
(29)
Female
(29)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Infectious Diseases
(26)
Middle Aged
(26)
Gastroenterology & Hepatology
(25)
Adenine - Analogs & Derivatives
(24)
Hepatitis B, Chronic - Drug Therapy
(24)
Antiviral Agents - Therapeutic Use
(18)
Viral Diseases
(18)
Adenine - Therapeutic Use
(17)
Human Viral Diseases
(17)
Organophosphonates
(17)
Hepatitis B Virus - Genetics
(16)
Hepatitis B, Chronic - Virology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy

Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin

An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign‐Born Persons Living in the United States

Chronic hepatitis B: A wave of new therapies on the horizon

Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States

Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States

Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

Adefovir dipivoxil therapy for lamivudine‐resistant hepatitis B in pre– and post–liver transplantation patients

Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease : a randomized, placebo-controlled trial

Suchergebnisse filtern